New smart glasses could track Parkinson’s symptoms

News

Author: Simge Eva DoganPublished: 25 October 2018

Prep: Cook: Serves:

Two European technology companies have received a grant from British public body Innovate UK to design smart glasses that could track Parkinson’s symptoms.

The companies – Emteq and audEERING – specialise in creating devices that track emotional responses. Designers plan to combine voice analysis technology with facial expression tracking features to identify patterns which indicate neurological conditions.

The creators believe the technology will help detect early symptoms of Parkinson’s, enabling doctors to better diagnose the condition.

Graeme Cox, CEO at Emteq, said: “By adding vocal biomarker analysis to our emotion AI platform, this collaboration will provide significant value to our drive to monitor key symptom levels in Parkinson’s Disease.”

A clinical trial for the glasses will take place in late 2019, with the glasses becoming commercially available the following year.

To read more on this topic click here.

For more information on assessment tools and Parkinson’s please visit the EPDA website.

Last Month

Next Month

Go Back

Share this story

Comments

PD in Practice

6 tips for improving speech in Parkinson’s

How to get the most from speech therapy sessions with PwPs

How the world reacted to the first US live Parkinson’s brain surgery

People took to social media to voice opinions on ‘Brain Surgery Live’

Watch: 13 people with Parkinson’s on the impact of exercise

How exercise can help manage Parkinson’s symptoms

Is there a link between Parkinson’s disease and blood vessel dysfunction?

Scientists in Slovakia have investigated the link between blood vessel dysfunction and Parkinson’s – and found that dopamine agonists may have an impact. The team studied the function of the endothelium – a membrane which lines the heart and blood vessels and helps control blood fluidity – in 41 people with the condition and 41 people without. Endothelial function was then measured through a parameter that assessed how easily blood could flow through the vessels. The results showed that while more people with Parkinson’s had endothelial dysfunction compared to those without, the difference did not reach statistical significance. However, the researchers noted that the findings suggested “an association between smoking, dopamine agonists, and impaired endothelial function” in those with the condition. Outlining the study’s limitations, the team noted that more research is needed to explore this potential link.

New swab test may help with Parkinson’s disease diagnosis

Researchers at the University of Manchester, UK, have drawn on one woman’s sense of smell to develop a swab test that may be used to detect Parkinson’s. The scientists used the test to analyse sebum (a type of oily substance on the skin) in 79 people with Parkinson’s and a control group of 71 healthy individuals. The team identified more than 4,000 different compounds in the participant samples – including 500 that were unique to those living with the condition. The test was developed with the help of Joy Milne from Perth, Scotland, whose unique sense of smell meant that she noticed a change in her late husband Les’s odour twelve years before he was diagnosed with Parkinson’s. Speaking to the BBC, Professor Perdita Barran, who led the research, described the test as potentially “transformative” – and said that the team hopes to roll the test out to people in…

Could a national biobank help inform the future of Parkinson’s disease treatment in Australia?

A biobank is a collection of biological samples and data designed to be used for research. Now, researchers in Australia are working to build a biobank for Parkinson’s. As part of the project, the scientists are conducting scans of people that have been injected with fluorodopa – a substance that highlights dopamine in the brain. Participants include people living with Parkinson’s and a control group of people without the condition. The resulting database of scans will be used to create a national biobank that aims to inform treatment and research into the condition. Commenting on the study, Olivia Nasser – executive director at the Hospital Research Foundation, which is helping to fund the research – said, “Once we build up the biobank of scans, it can actually be used as an effective way to treat Parkinson’s.” The researchers encourage people with and without Parkinson’s to take part in the trial.

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Phone
This field is for validation purposes and should be left unchanged.

New smart glasses could track Parkinson’s symptoms

News

Author: Simge Eva DoganPublished: 25 October 2018

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

PD in Practice

6 tips for improving speech in Parkinson’s

Perspectives

How the world reacted to the first US live Parkinson’s brain surgery

Health & Fitness

Watch: 13 people with Parkinson’s on the impact of exercise

Is there a link between Parkinson’s disease and blood vessel dysfunction?

New swab test may help with Parkinson’s disease diagnosis

Could a national biobank help inform the future of Parkinson’s disease treatment in Australia?

{title}

Subscribe

New smart glasses could track Parkinson’s symptoms

News

Author: Simge Eva DoganPublished: 25 October 2018

Last Month

Next Month

Share this story

Comments

Related articles

PD in Practice

6 tips for improving speech in Parkinson’s

Perspectives

How the world reacted to the first US live Parkinson’s brain surgery

Health & Fitness

Watch: 13 people with Parkinson’s on the impact of exercise

Is there a link between Parkinson’s disease and blood vessel dysfunction?

New swab test may help with Parkinson’s disease diagnosis

Could a national biobank help inform the future of Parkinson’s disease treatment in Australia?

{title}

Subscribe

Sign in